Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
atrial fibrillation paroxysmal, atrial fibrillation and flutter, paroxysmal atrial fibrillation and flutter, cardioversion af, amiodarone, refralon, niferidil, new antiarrhythmic drug, new russian antiarrhythmic drug refralon, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 890549
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.